Mechanisms of HIV type 1-induced cognitive impairment: Evidence for hippocampal cholinergic involvement with overstimulation of the VIPergic system by the viral coat protein core

AIDS Research and Human Retroviruses

Volumn 18, Issue 16, 2002, Pages 1189-1195

  Farr, Susan A ^a   Banks, William A ^a   Uezu, Kayoko ^a   Freed, Eric O ^b   Kumar, Vijaya B ^a   Morley, John E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARECOLINE; GLYCOPROTEIN GP 120;

ANIMAL MODEL; ARTICLE; BRAIN VENTRICLE; CHOLINERGIC STIMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLYCATION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHOCK; VIRUS GENOME;

AIDS DEMENTIA COMPLEX; ANIMALS; CAPSID PROTEINS; HIPPOCAMPUS; HIV-1; MALE; MICE; RECEPTORS, CHOLINERGIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036435058     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260387931     Document Type: Article

References (44)

1. Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bemaldo de Quiros JC, Munoz L, Moreno S, and Bouza E: Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998; 12:2467-2472.
2. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Jr, and Swindells S: Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 1998;178:1000-1007.
3. Chen P, Mayne M, Power C, and Nath A: The Tat protein of HIV1 induces rumor necrosis factor-α production: Implications for HIV-1-associated neurological diseases. J Biol Chem 1997;272: 22385-22388.
4. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, and Krohn K: Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995;9:1001-1008.
5. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, Chaikin MA, Shaw GW, and Benveniste EN: Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994;91:494-498.
6. +]i increases in a glial cell subpopulation. Eur J Neurosci 1993 ;5:1711-1718.
7. Corasaniti MT, Melino G, Navarra M, Garaci E, Finazzi-Agro A, and Nistico G: Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 1995;4:315-321.
8. Dawson VL, Dawson TM, Uhl GR, and Snyder SH: Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993;90:3256-3259.
9. Fujimura RK, Bockstahler LE, Goodkin K, Werner T, Brack-Werner R, and Shapshak P: Neuropathology and virology of HIV associated dementia. Med Virol 1996;6:141-150.
10. Kimes AS, London ED, Szabo G, Raymon L, and Tabakoff B: Reduction of cerebral glucose utilization by the HIV envelope glycoprotein gp-120. Exp Neurol 1991;112:224-228.
11. Ilyin SE and Plata-Salaman CR: HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: Implications to cytokine feedback systems. Biochem Biophys Res Commun 1997;231:514-518.
12. Nair MPN, Sweet AM, and Schwartz SA: Immunoregulation of tumor necrosis factor production by HIV-1 gp-120 in neonates and adults. Ann NY Acad Sci 1993;693:309-311.
13. Yamaguchi Y: Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat. Neuropeptides 1994;26:153-158.
14. Itoh S, Takashima A, Morimoto T: Impaired spatial learning by vasoactive intestinal peptide in Morris water maze task in the rat. Can J Physiol Pharmacol 1994;72:25-29.
15. Freed EO and Martin MA: Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 1995;69:1984-1989.
16. Murakami T and Freed EO: The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci USA 2000;97:343-348.
17. Farr SA, Uezu K, Flood JF, and Morley JE: Septo-hippocampal drug interactions in post-trial memory processing. Brain Res 1999;847:221-230.
18. Farr SA, Flood JF, and Morley JE: The effect of cholinergic, GABAergic, serotonergic and glutamatergic receptor modulation on post-trial memory processing in the hippocampus. Neurobiol Learn Mem 2000;73:150-167.
19. Slotnick BM and Leonard CM: A Stereotaxic Atlas of the Albino Mouse Forebrain. Government Printing Office, Washington, D.C., 1975.
20. Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, and Hill JM: Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 1992;570:49-53.
21. Hill JM, Mervis RF, Avidor R, Moody TW, and Brenneman DE: HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 1993;603:222-233.
22. Banks WA, Kastin AJ, and Akerstrom V: HIV-1 protein gp120 crosses the blood-brain barrier: Role of adsorptive endocytosis. Life Sci 1997;61:L119-L125.
23. Banks WA, Kastin AJ, Brennan JM, and Vallance KL: Adsorptive endocytosis of HIV-1 gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol 1999;156:165-171.
24. Flood JF, Garland JS, and Morley JE: Vasoactive intestinal peptide (VIP): An amnestic neuropeptide. Peptides 1990;11:933-938.
25. McGaugh JL: Drug facilitation of learning and memory. Ann Rev Pharmacol 1973;13:229-241.
26. Matsumoto Y, Yoshida T, Watanabe S, and Yamamoto T: Involvement of cholinergic and glutamatergic functions in working memory impairment induced by interleukin-1 beta in rats. Eur J Pharmacol 2001;430:283-288.
27. Kelles A, Janssens J, and Tack J: IL-1 beta and IL-6 excite neurons and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig. Neurogastroenterol Motil 2000;12:531-538.
28. Bracci L, Lozzi L, Rustici M, and Neri P: Binding of HIV-1 gp120 to the nicotinic receptor. FEBS Lett 1992;311:115-118.
29. Bracci L, Ballas SK, Spreafico A, and Neri P: Molecular mimicry betwen rabies virus glycoprotein and human immunodeficiency virus-1 GP120: Cross-reacting antibodies induced by rabies vaccination. Blood 1997;90:3623-3628.
30. Chang J, Jozwiak R, Wang B, Ng T, Ge YC, Bolton W, Dwyer DE, Randle C, Osborn R, Cunningham AL, and Saksena NK: Unique HIV type 1 V3 region sequences derived from six different regions of brain: Region-specific evolution within host-determined quasispecies. AIDS Res Hum Retroviruses 1998;14:25-30.
31. Moses AV, Stenglein SG, Strussenberg JG, Wehrly K, Chesebro B, and Nelson JA: Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region of the viral genome. J Virol 1996;70:3401-3406.
32. Fenouillet E, Gluckman JC, and Jones IM: Functions of HIV envelope glycans. Trends Biochem Sci 1994;19:65-70.
33. Kong LY, Wilson BC, McMillian MK, Bing G, Hudson PM, and Hong JS: The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996;172:77-83.
34. Shapshak P, Segal DM, Crandall KA, Fujimura RK, Zhang BT, Xin KQ, Okuda K, Petito CK, Eisdorfer C, and Goodkin K: Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses 1999;15:811-820.
35. Banks WA, Akerstrom V, and Kastin AJ: Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: Evidence for a post-internalization coreceptor. J Cell Sci 1998;111:533-540.
36. Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, and Jensenius JC: Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307-1313.
37. Velikovic V, Metlas R, Danilo V, Cavor L, Pejinovic N, Dujuc A, Zakhariev S, Guamaccia C, and Pongor S: Natural autoantibodies cross-react with a peptide derived from the second conserved region of HIV-1 envelope gylcoprotein gp120. Biochem Biophys Res Commun 1993;196:1019-1024.
38. Buzy J, Brenneman DE, Pert CB, Martin A, Salazar A, and Ruff MR: Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T. Brain Res 1992;598:10-18.
39. Velikovic V, Metlas R, Raspopovic J, and Pongor S: Spectral and sequence similarity between vasoactive intestinal peptide and the second conserved region of human immunodeficiency virus type 1 envelope glycoprotein (gp120): Possible consequences on prevention and therapy of AIDS. Biochem Biophys Res Commun 1992;189:705-710.
40. Eckenstein F and Baughman RW: Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide. Nature 1984;309:153-155.
41. Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, and Audinat E: Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci 1999;19:5228-5235.
42. Masuo Y, Matsumoto Y, Tokito F, Tsuda M, and Fujino M: Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activiation polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis. Brain Res 1993;611:207-215.
43. Kaji H, Chihara K, Minamitani N, Kodama H, Yanaihara N, and Fujita T: Release of vasoactive intestinal polypeptide into the cerebrospinal fluid of the fourth ventricle of the rat: Involvement of cholinergic mechanism. Brain Res 1983;269:303-310.
44. Lindh B and Hokfelt T: Structural and functional aspects of acetycholine peptide coexistence in the autonomic nervous system. Prog Brain Res 1990;84:175-191.